Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-10-24 Sale | 2025-10-28 5:00 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 2,444 | $14.01 | $34,237 | 396,089 (Indirect Direct) | View |
| 2025-10-09 Sale | 2025-10-14 4:05 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 3,600 | $14.09 | $50,706 | 398,533 (Indirect Direct) | View |
| 2025-10-02 Sale | 2025-10-03 8:24 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 500 | $14.13 | $7,065 | 402,133 (Indirect Direct) | View |
| 2025-09-29 Sale | 2025-10-01 5:46 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 1,300 | $14.01 | $18,213 | 402,633 (Indirect Direct) | View |
| 2025-09-24 Sale | 2025-09-26 8:35 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 9,371 | $14.06 | $131,779 | 403,933 (Indirect Direct) | View |
| 2025-08-27 Sale | 2025-08-29 8:34 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 5,029 | $13.99 | $70,356 | 413,304 (Indirect Direct) | View |
| 2023-09-05 Purchase | 2023-09-06 3:28 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 40,000 | $0.9047 | $36,188 | 6,410,000 (Indirect Direct) | View |
| 2023-09-01 Purchase | 2023-09-05 06:05 am | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 70,000 | $0.9135 | $63,945 | 6,370,000 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-23 Option Award(A) | 2025-03-24 8:38 pm | 2026-02-01 2035-01-22 | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 65,000 | $0 | 65,000 (Direct) | View |
| 2025-01-23 Option Award | 2025-01-24 6:10 pm | 2026-02-01 2030-01-22 | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 65,000 | $0 | 65,000 (Direct) | View |
| 2024-04-10 Gift | 2024-04-10 5:30 pm | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 50,000 | $0 | 6,275,000 (Direct) | View |
| 2023-10-23 Gift | 2024-02-12 9:41 pm | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 85,000 | $0 | 6,325,000 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-19 7:40 pm | N/A 2034-01-17 | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X Chief Executive Officer 10% Owner | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-13 09:00 am | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 25,000 | $1.94 | 6,300,000 (Direct) | View |
Ownership | 2023-01-19 8:23 pm | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 0 | $0 | 6,275,000 (Direct) | View |